eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

4/2020
vol. 12
 
Share:
Share:
more
 
 
abstract:
Original paper

Interstitial high-dose-rate brachytherapy using cobalt-60 source for cervical cancer: dosimetric and clinical outcomes from a single institute

Mohan Kumar
1
,
Revathy Thangaraj
1
,
Ram Charith Alva
1
,
Kirthi Koushik
1
,
Arul Ponni
1
,
Manur Gururajachar Janaki
1

1.
Ramaiah Medical College, Bengaluru, India
J Contemp Brachytherapy 2020; 12, 4: 351–355
Online publish date: 2020/08/21
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
To record and report dosimetric and clinical outcomes of interstitial brachytherapy using cobalt-60 (60Co) source in cervical cancer.

Material and methods
Seventy patients who underwent external beam radiotherapy with dose of 45 Gy in 25 fractions, followed by interstitial brachytherapy (ISBT) 6.5 Gy × 4 fractions were included into this study. The ISBT applicators were inserted under combined spinal and epidural anesthesia. Computed tomography (CT) simulation was performed and axial CT images were transferred to treatment planning system. High-risk clinical target volume (CTVHR) and organs at risks (OARs) were contoured. Four fractions of 6.5 Gy were prescribed to CTVHR using inverse planning technique. Patients were followed-up for 3 years. Dosimetric parameters and clinical outcomes were recorded and compared with available literature.

Results
Seventy patients with FIGO stage IIB-IVA were included in the study. The median EQD2 of 2 cm3 of bladder, rectum, sigmoid and D90 D90 were 70 Gy (53-75 Gy), 64 Gy (51-71 Gy), 48 Gy (44-72 Gy), and 77 Gy (70-86 Gy), and dose homogeneity index (DHI), dose non-uniformity ratio (DNR), coverage index (CI), overdose volume index (OI), and conformal index (COIN) were 0.58 (0.39-0.78), 0.42 (0.22-0.61), 0.87 (0.59-0.97), 0.19 (0.09-0.30) and 0.74 (0.52-0.85), respectively. Local control rate at 2 years was 87.14%. Eight patients had local recurrence and one patient had lung metastasis. Also, two patients with local recurrence had recto-vaginal fistula. Two patients had grade 2 proctitis (2.8%) and one patient developed grade 3 proctitis (1.4%). There was no grade 2 or higher bladder toxicity.

Conclusions
The dosimetric parameters, local control and toxicities of high-dose-rate interstitial brachytherapy in cervical cancer patients treated by 60Co radioactive source are similar, compared to available literature using iridium-192 (192Ir) source.

keywords:

interstitial brachytherapy, cobalt-60, cervical cancer

 
Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe